© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 15, 1295-1303,
August 4, 1999
© 1999 Oxford University Press
Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers
Affiliations of authors: K. C. Halling, A. J. French, L. J. Burgart, L. Moon-Tasson, S. N. Thibodeau (Departments of Laboratory Medicine and Pathology), S. K. McDonnell, D. J. Schaid, B. J. Peterson, M. R. Mahoney, D. J. Sargent (Health Sciences Research, Section of Biostatistics), T. E. Witzig (Internal Medicine, Division of Hematology), Mayo Foundation, Rochester, MN; M. J. O'Connell, G. H. Farr, Jr., R. M. Goldberg, North Central Cancer Treatment Group, Rochester.
Correspondence to: Stephen N. Thibodeau, Ph.D., Laboratory Genetics/HI 970, Mayo Clinic, 200 First St., SW, Rochester, MN 55905 (e-mail: sthibodeau{at}mayo.edu).
BACKGROUND: Microsatellite instability (MSI) and allelic imbalance involving chromosome arms 5q, 8p, 17p, and 18q are genetic alterations commonly found in colorectal cancer. We investigated whether the presence or absence of these genetic alterations would allow stratification of patients with Astler-Coller stage B2 or C colorectal cancer into favorable and unfavorable prognostic groups. METHODS: Tumors from 508 patients were evaluated for MSI and allelic imbalance by use of 11 microsatellite markers located on chromosome arms 5q, 8p, 15q, 17p, and 18q. Genetic alterations involving each of these markers were examined for associations with survival and disease recurrence. All P values are two-sided. RESULTS: In univariate analyses, high MSI (MSI-H), i.e., MSI at 30% or more of the loci examined, was associated with improved survival (P = .02) and time to recurrence (P = .01). The group of patients whose tumors exhibited allelic imbalance at chromosome 8p had decreased survival (P = .02) and time to recurrence (P = .004). No statistically significant associations with survival or time to recurrence were observed for markers on chromosome arms 5q, 15q, 17p, or 18q. In multivariate analyses, MSI-H was an independent predictor of improved survival (hazard ratio [HR] = 0.51; 95% confidence interval [CI] = 0.31-0.82; P = .006) and time to recurrence (HR = 0.42; 95% CI = 0.24-0.74; P = .003), and 8p allelic imbalance was an independent predictor of decreased survival (HR = 1.89; 95% CI = 1.25-2.83; P = .002) and time to recurrence (HR = 2.07; 95% CI = 1.32-3.25; P = .002). CONCLUSIONS: Patients whose tumors exhibited MSI-H had a favorable prognosis, whereas those with 8p allelic imbalance had a poor prognosis; both alterations served as independent prognostic factors. To our knowledge, this is the first report of an association between 8p allelic imbalance and survival in patients with colorectal cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Jiang, G. Casey, I. C. Lavery, Y. Zhang, D. Talantov, M. Martin-McGreevy, M. Skacel, E. Manilich, A. Mazumder, D. Atkins, et al. Development of a Clinically Feasible Molecular Assay to Predict Recurrence of Stage II Colon Cancer J. Mol. Diagn., July 1, 2008; 10(4): 346 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. French, D. J. Sargent, L. J. Burgart, N. R. Foster, B. F. Kabat, R. Goldberg, L. Shepherd, H. E. Windschitl, and S. N. Thibodeau Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer Clin. Cancer Res., June 1, 2008; 14(11): 3408 - 3415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Leopoldo, B. Lorena, A. Cinzia, D. C. Gabriella, B. A. Luciana, C. Renato, M. Antonio, S. Carlo, P. Cristina, C. Stefano, et al. Two Subtypes of Mucinous Adenocarcinoma of The Colorectum: Clinicopathological and Genetic Features Ann. Surg. Oncol., May 1, 2008; 15(5): 1429 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Z. Pang, L.-X. Qin, N. Ren, Z.-Y. Hei, Q.-H. Ye, W.-D. Jia, B.-S. Sun, G.-L. Lin, D.-Y. Liu, Y.-K. Liu, et al. Loss of Heterozygosity at D8S298 Is a Predictor for Long-term Survival of Patients with Tumor-Node-Metastasis Stage I of Hepatocellular Carcinoma Clin. Cancer Res., December 15, 2007; 13(24): 7363 - 7369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Malesci, L. Laghi, P. Bianchi, G. Delconte, A. Randolph, V. Torri, C. Carnaghi, R. Doci, R. Rosati, M. Montorsi, et al. Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer Clin. Cancer Res., July 1, 2007; 13(13): 3831 - 3839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Y. Locker, S. Hamilton, J. Harris, J. M. Jessup, N. Kemeny, J. S. Macdonald, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer J. Clin. Oncol., November 20, 2006; 24(33): 5313 - 5327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Andre, D. Sargent, J. Tabernero, M. O'Connell, M. Buyse, A. Sobrero, J.-L. Misset, C. Boni, and A. de Gramont Current Issues in Adjuvant Treatment of Stage II Colon Cancer Ann. Surg. Oncol., June 1, 2006; 13(6): 887 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Jover, P Zapater, A Castells, X Llor, M Andreu, J Cubiella, V Pinol, R M Xicola, L Bujanda, J M Rene, et al. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer Gut, June 1, 2006; 55(6): 848 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lanza, R. Gafa, A. Santini, I. Maestri, L. Guerzoni, and L. Cavazzini Immunohistochemical Test for MLH1 and MSH2 Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients J. Clin. Oncol., May 20, 2006; 24(15): 2359 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-A. Park, K. Y. Lee, N. K. Kim, S. H. Baik, S. K. Sohn, and C. W. Cho Prognostic Effect of Perioperative Change of Serum Carcinoembryonic Antigen Level: A Useful Tool for Detection of Systemic Recurrence in Rectal Cancer Ann. Surg. Oncol., May 1, 2006; 13(5): 645 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Sinicrope, R. L. Rego, K. C. Halling, N. R. Foster, D. J. Sargent, B. La Plant, A. J. French, C. J. Allegra, J. A. Laurie, R. M. Goldberg, et al. Thymidylate synthase expression in colon carcinomas with microsatellite instability. Clin. Cancer Res., May 1, 2006; 12(9): 2738 - 2744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamamoto, H. Matsuyama, S. Kawauchi, T. Furuya, X. P. Liu, K. Ikemoto, A. Oga, K. Naito, and K. Sasaki Biological characteristics in bladder cancer depend on the type of genetic instability. Clin. Cancer Res., May 1, 2006; 12(9): 2752 - 2758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Watanabe, T. Kanazawa, Y. Kazama, J. Tanaka, T. Tanaka, S. Ishihara, and H. Nagawa TP53 Mutation and Microsatellite Instability Status for the Prediction of Survival in Adjuvant-Treated Colon Cancer Patients J. Clin. Oncol., December 10, 2005; 23(35): 9031 - 9032. [Full Text] [PDF]
|
|
|
|
|
|
P. Benatti, R. Gafa, D. Barana, M. Marino, A. Scarselli, M. Pedroni, I. Maestri, L. Guerzoni, L. Roncucci, M. Menigatti, et al. Microsatellite Instability and Colorectal Cancer Prognosis Clin. Cancer Res., December 1, 2005; 11(23): 8332 - 8340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Westra, M. Schaapveld, H. Hollema, J. P. de Boer, M. M.J. Kraak, D. de Jong, A. ter Elst, N. H. Mulder, C. H.C.M. Buys, R. M.W. Hofstra, et al. Determination of TP53 Mutation Is More Relevant Than Microsatellite Instability Status for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage III Colon Cancer Patients J. Clin. Oncol., August 20, 2005; 23(24): 5635 - 5643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Samowitz, C. Sweeney, J. Herrick, H. Albertsen, T. R. Levin, M. A. Murtaugh, R. K. Wolff, and M. L. Slattery Poor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon Cancers Cancer Res., July 15, 2005; 65(14): 6063 - 6069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R.J. Kohonen-Corish, J. J. Daniel, C. Chan, B. P.C. Lin, S. Y. Kwun, O. F. Dent, V. S. Dhillon, R. J.A. Trent, P. H. Chapuis, and E. L. Bokey Low Microsatellite Instability Is Associated With Poor Prognosis in Stage C Colon Cancer J. Clin. Oncol., April 1, 2005; 23(10): 2318 - 2324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Popat, R. Hubner, and R.S. Houlston Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis J. Clin. Oncol., January 20, 2005; 23(3): 609 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. French, G. Petroni, S. N. Thibideau, M. Smolkin, E. Bissonette, F. Roviello, J. C. Harper, B. R. Koch, S. A. Anderson, S. J. Hebbring, et al. Allelic Imbalance of 8p Indicates Poor Survival in Gastric Cancer J. Mol. Diagn., August 1, 2004; 6(3): 243 - 252. [Abstract] [Full Text]
|
|
|
|
|
|
G. Bardi, C. Fenger, B. Johansson, F. Mitelman, and S. Heim Tumor Karyotype Predicts Clinical Outcome in Colorectal Cancer Patients J. Clin. Oncol., July 1, 2004; 22(13): 2623 - 2634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gill, C. L. Loprinzi, D. J. Sargent, S. D. Thome, S. R. Alberts, D. G. Haller, J. Benedetti, G. Francini, L. E. Shepherd, J. Francois Seitz, et al. Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much? J. Clin. Oncol., May 15, 2004; 22(10): 1797 - 1806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, T. Jatkoe, Y. Zhang, M. G. Mutch, D. Talantov, J. Jiang, H. L. McLeod, and D. Atkins Gene Expression Profiles and Molecular Markers To Predict Recurrence of Dukes' B Colon Cancer J. Clin. Oncol., May 1, 2004; 22(9): 1564 - 1571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Parc, S Gueroult, N Mourra, L Serfaty, J-F Flejou, E Tiret, and R Parc Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer Gut, March 1, 2004; 53(3): 371 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kambara, G. B. Sharp, T. Nagasaka, M. Takeda, H. Sasamoto, H. Nakagawa, H. Isozaki, D. G. MacPhee, J. R. Jass, N. Tanaka, et al. Allelic Loss of a Common Microsatellite Marker MYCL1: A Useful Prognostic Factor of Poor Outcomes in Colorectal Cancer Clin. Cancer Res., March 1, 2004; 10(5): 1758 - 1763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Emterling, A. Wallin, G. Arbman, and X.-F. Sun Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer Ann. Onc., February 1, 2004; 15(2): 242 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Ward, K. Cheong, S.-L. Ku, A. Meagher, T. O'Connor, and N. J. Hawkins Adverse Prognostic Effect of Methylation in Colorectal Cancer Is Reversed by Microsatellite Instability J. Clin. Oncol., October 15, 2003; 21(20): 3729 - 3736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ishikawa, T. Fujita, Y. Suzuki, S. Okabe, Y. Yuasa, T. Iwai, and Y. Kawakami Tumor-specific Immunological Recognition of Frameshift-mutated Peptides in Colon Cancer with Microsatellite Instability Cancer Res., September 1, 2003; 63(17): 5564 - 5572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mori, F. M. Selaru, F. Sato, J. Yin, L. A. Simms, Y. Xu, A. Olaru, E. Deacu, S. Wang, J. M. Taylor, et al. The Impact of Microsatellite Instability on the Molecular Phenotype of Colorectal Tumors Cancer Res., August 1, 2003; 63(15): 4577 - 4582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Ribic, D. J. Sargent, M. J. Moore, S. N. Thibodeau, A. J. French, R. M. Goldberg, S. R. Hamilton, P. Laurent-Puig, R. Gryfe, L. E. Shepherd, et al. Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer N. Engl. J. Med., July 17, 2003; 349(3): 247 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Graziano and S. Cascinu Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann. Onc., July 1, 2003; 14(7): 1026 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Diep, L. Thorstensen, G. I. Meling, E. Skovlund, T. O. Rognum, and R. A. Lothe Genetic Tumor Markers With Prognostic Impact in Dukes' Stages B and C Colorectal Cancer Patients J. Clin. Oncol., March 1, 2003; 21(5): 820 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nakata, Y. Qing Wang, M. Yashiro, N. Nishioka, H. Tanaka, M. Ohira, T. Ishikawa, H. Nishino, and K. Hirakawa Prognostic Value of Microsatellite Instability in Resectable Pancreatic Cancer Clin. Cancer Res., August 1, 2002; 8(8): 2536 - 2540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-W. Choi, K. J. Lee, Y.-A. Bae, K.-O. Min, M.-S. Kwon, K.-M. Kim, and M.-G. Rhyu Genetic Classification of Colorectal Cancer Based on Chromosomal Loss and Microsatellite Instability Predicts Survival Clin. Cancer Res., July 1, 2002; 8(7): 2311 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dolcetti, M. Guidoboni, A. Viel, M. Boiocchi, W. S. Samowitz, and M. L. Slattery Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10: 917-923, 2001 Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 499 - 500. [Full Text] [PDF]
|
|
|
|
|
|
S. Halford, P. Sasieni, A. Rowan, H. Wasan, W. Bodmer, I. Talbot, N. Hawkins, R. Ward, and I. Tomlinson Low-Level Microsatellite Instability Occurs in Most Colorectal Cancers and Is a Nonrandomly Distributed Quantitative Trait Cancer Res., January 1, 2002; 62(1): 53 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kambara, N. Matsubara, H. Nakagawa, K. Notohara, T. Nagasaka, T. Yoshino, H. Isozaki, G. B. Sharp, K. Shimizu, J. Jass, et al. High Frequency of Low-Level Microsatellite Instability in Early Colorectal Cancer Cancer Res., November 1, 2001; 61(21): 7743 - 7746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Samowitz, K. Curtin, K.-N. Ma, D. Schaffer, L. W. Coleman, M. Leppert, and M. L. Slattery Microsatellite Instability in Sporadic Colon Cancer Is Associated with an Improved Prognosis at the Population Level Cancer Epidemiol. Biomarkers Prev., September 1, 2001; 10(9): 917 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guidoboni, R. Gafa, A. Viel, C. Doglioni, A. Russo, A. Santini, L. Del Tin, E. Macri, G. Lanza, M. Boiocchi, et al. Microsatellite Instability and High Content of Activated Cytotoxic Lymphocytes Identify Colon Cancer Patients with a Favorable Prognosis Am. J. Pathol., July 1, 2001; 159(1): 297 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Ward, A Meagher, I Tomlinson, T O'Connor, M Norrie, R Wu, and N Hawkins Microsatellite instability and the clinicopathological features of sporadic colorectal cancer Gut, June 1, 2001; 48(6): 821 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Watanabe, T.-T. Wu, P. J. Catalano, T. Ueki, R. Satriano, D. G. Haller, A. B. Benson, and S. R. Hamilton Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer N. Engl. J. Med., April 19, 2001; 344(16): 1196 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamamoto, F. Itoh, H. Nakamura, H. Fukushima, S. Sasaki, M. Perucho, and K. Imai Genetic and Clinical Features of Human Pancreatic Ductal Adenocarcinomas with Widespread Microsatellite Instability Cancer Res., April 1, 2001; 61(7): 3139 - 3144. [Abstract] [Full Text]
|
|
|
|
|
|
J. Andreyev and D. Cunningham Markers, Markers Everywhere . . . . . Prognosis in Colorectal Cancer--Time for a New Approach J. Clin. Oncol., January 15, 2001; 19(2): 286 - 288. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ionov, H. Yamamoto, S. Krajewski, J. C. Reed, and M. Perucho Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution PNAS, September 8, 2000; (2000) 190210897. [Abstract] [Full Text]
|
|
|
|
|
|
M. Ponz de Leon, L. Roncucci, K. Heinimann, H. Muller, Z. Dobbie, R. Gryfe, M. Redston, and S. Gallinger Microsatellite Instability in Colorectal Cancer N. Engl. J. Med., May 25, 2000; 342(21): 1607 - 1608. [Full Text]
|
|
|
|
|
|
R. Gryfe, H. Kim, E. T.K. Hsieh, M. D. Aronson, E. J. Holowaty, S. B. Bull, M. Redston, and S. Gallinger Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer N. Engl. J. Med., January 13, 2000; 342(2): 69 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Offit Genetic Prognostic Markers for Colorectal Cancer N. Engl. J. Med., January 13, 2000; 342(2): 124 - 125. [Full Text]
|
|
|
|
 |
|
 I. D. Nicholl and M. G. Dunlop Molecular Markers of Prognosis in Colorectal Cancer J Natl Cancer Inst, August 4, 1999; 91(15): 1267 - 1269. [Full Text] [PDF]
|
|
|
|
|
|
Y. Ionov, H. Yamamoto, S. Krajewski, J. C. Reed, and M. Perucho Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution PNAS, September 26, 2000; 97(20): 10872 - 10877. [Abstract] [Full Text] [PDF]
|
|